Skip main navigation
×

Rotors

How Do We Know When They Are Real?
Originally publishedhttps://doi.org/10.1161/CIRCEP.117.005634Circulation: Arrhythmia and Electrophysiology. 2017;10:e005634

    See Article by Rodrigo et al

    A spiral wave is a common macroscopic behavior of excitable media observed in biological, chemical, and physical systems.1,2 In cardiac tissues, spiral wave reentry occurs when a wavefront of electric propagation encounters functionally inexcitable tissue and rotates around it in a vortex-like fashion.3 A rotor of a spiral wave is a rotation center from which a 2-dimensional spiral wave of excitation rotates outward. Phase mapping has been the de facto standard method to identify rotors and to track their trajectories in animal models of fibrillation.4 On phase maps, a rotor is defined as a phase singularity point around which the phase transitions through a complete cycle from −π to +π.3,5 Phase mapping can falsely detect phase singularities in the absence of rotors,6 and spiral waves can exist without phase singularities.7 Rotors and focal impulses have been proposed to be the underlying drivers of atrial fibrillation (AF) in human.3,8,9 This localized source hypothesis has resulted in the utilization of phase mapping in clinical practice, mainly in 2 settings: invasive focal impulse and rotor modulation (FIRM) and noninvasive electrocardiographic imaging (ECGI).

    FIRM uses phase mapping to locate stable rotors based on endocardial unipolar electrograms acquired by a 64-lead basket catheter.9 ECGI uses phase mapping to locate rotors based on unipolar electrograms acquired by ≈250 body surface electrocardiographic leads, which are back projected onto the epicardial surface, using a technique called inverse solution. FIRM and ECGI have several limitations, in addition to the intrinsic limitations of phase mapping. FIRM may not show consistent results when compared with other methods of rotor detection. FIRM-detected rotors were confirmed by an independent phase-based mapping method10 but were not reproduced by a different mapping method.11 FIRM mapping may reflect endocardial activation more than epicardial or intramural activation. ECGI is limited by a relatively large localization error, ≤4 cm, and may not reflect endocardial activation patterns. A significant proportion of this error is introduced by the inverse solution methodology.12

    Early clinical studies using FIRM-guided AF ablation showed promising results.9,13,14 However, these results are variable in more recent studies.9 Likewise, although ECGI-guided driver ablation terminated 75% of persistent AF and 15% of long-standing persistent AF,15 in a different study that used the same ECGI technology, only rare rotor activity was described in AF.16 It is possible that technical limitations in rotor mapping (Figure) are solely responsible for the conflicting clinical evidence described above. However, the contradictory clinical evidence has led to a growing skepticism in the electrophysiology community, about the presence and role of rotors in AF.17 The localized source hypothesis is currently in jeopardy, whereas alternative—but not mutually exclusive—hypotheses of AF mechanisms are being developed.18–20 Nevertheless, a scientific hypothesis should not be rejected on the basis of technical limitations, but rather be tested by transparent and carefully designed studies, which are essential for improving our understanding of the true mechanism underlying human AF.

    Figure.

    Figure. Schematic summary of the steps involved in rotor identification and the relevant technical considerations for each step. Highlighted with an asterisk (*) are the considerations that the current work of Rodrigo et al6 successfully addressed as described in the main text. BSPM indicates body surface potential mapping; ECGI, noninvasive electrocardiographic imaging; and EGM, electrogram.

    In elegant work published in this issue of the Circulation: Arrhythmia and Electrophysiology, Rodrigo et al6 made a large stride to address the technical limitations associated with rotor mapping using ECGI. Rotor mapping is a complex multistep process that involves data acquisition, filtering, phase mapping, and rotor detection algorithms (Figure). The authors use in silico simulations of AF (1) to develop a phase mapping–based method for rotor detection with optimal sensitivity and specificity and (2) to assess the effect of highest dominant frequency filtering on the accuracy of rotor identification. The authors demonstrate that the activation phase calculated for tissue in a circle of radius 1.5 cm, concentric to a phase singularity identified as a potential rotor, should progress monotonically and linearly from −π to +π. A deviation from linearity >0.4 rads is suggestive of a wavebreak and thus should not be identified as a rotor. In addition, only phase singularities that exhibit a rotational pattern lasting at least 2 complete rotations should be identified as stable rotors. These 2 simple criteria alone could achieve an optimal balance between sensitivity and specificity in rotor detection. Furthermore, unipolar cardiac electrograms directly measured at the endocardium or estimated with ECGI can be used in phase mapping without additional filtering, with good sensitivity and specificity for rotor detection. Highest dominant frequency filtering should be avoided in endocardial and ECGI-derived unipolar signals as it greatly decreases specificity for rotor detection. Moreover, bipolar electrograms and body surface potential mapping have inadequate sensitivity in detecting rotors. The sensitivity of bipolar electrograms and body surface potential mapping can be improved with the application of a highest dominant frequency filter, but this comes with a significant decline in specificity, and inappropriate identification of false rotors.

    The authors should be congratulated on their robust contribution to address the technical limitations associated with rotor mapping. The authors used an AF model with a realistic human atrial geometry, as well as noise added to the recorded signals to mimic real-life signal acquisition conditions. The constraints that they apply in rotor identification are physiologically plausible. Their rotor detection algorithm is easy to implement, computationally efficient, and significantly improves sensitivity and specificity in rotor identification. Importantly, the authors also demonstrate that highest dominant frequency filtering of endocardial or ECGI-derived unipolar electrograms is unnecessary and that bipolar electrograms or body surface potential signals are not ideal for rotor detection. Future studies should validate the results of this in silico study in more realistic conditions such as ex vivo torso tanks or in vivo large animals.

    Last, another technical limitation associated with rotor mapping is interelectrode distance of signal measurements. Roney et al21 report that the 64-lead basket catheter, routinely used in clinical practice, fails to accurately localize rotors because of a high interelectrode distance (>9–11 mm). In addition, King et al22 demonstrate that a higher interelectrode distance lowers both sensitivity and specificity of rotor detection. They also report that a band-pass filter falsely increases the temporal and spatial stability and the persistence of rotors. Furthermore, Kuklik et al23 showed that rotor detection is most accurate with a double-ring electrode configuration, comprising of 2×2 and 4×4 electrodes, suggesting that rotor detection also depends on electrode configuration. The simulated left atrium of Rodrigo et al6 contains a total of 2048 electrodes over the epicardial surface with an interelectrode distance of 1 mm. Unfortunately, a technology providing such high-density, high-resolution mapping is not available in clinical practice at this point. There is an urgent need for readily available, high-resolution mapping technologies.

    With the work of Rodrigo et al,6 we are one step closer to testing the localized source hypothesis as a potential mechanism of human AF. Future studies to address other aspects of technical limitations associated with rotor detection (Figure) would further advance our understanding of human AF and help expand our therapeutic armamentarium.

    Footnotes

    The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

    Circ Arrhythm Electrophysiol is available at http://circep.ahajournals.org.

    Correspondence to: Hiroshi Ashikaga, MD, PhD, Cardiac Arrhythmia Service, Johns Hopkins University School of Medicine, 600 N Wolfe St, Carnegie 568, Baltimore, MD 21287. E-mail

    References

    • 1. Winfree AT. Vortex action potentials in normal ventricular muscle.Ann N Y Acad Sci. 1990; 591:190–207.CrossrefMedlineGoogle Scholar
    • 2. Gray RA, Jalife J, Panfilov A, Baxter WT, Cabo C, Davidenko JM, Pertsov AM. Nonstationary vortexlike reentrant activity as a mechanism of polymorphic ventricular tachycardia in the isolated rabbit heart.Circulation. 1995; 91:2454–2469.CrossrefMedlineGoogle Scholar
    • 3. Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation.Nature. 1998; 392:75–78. doi: 10.1038/32164.CrossrefMedlineGoogle Scholar
    • 4. Umapathy K, Nair K, Masse S, Krishnan S, Rogers J, Nash MP, Nanthakumar K. Phase mapping of cardiac fibrillation.Circ Arrhythm Electrophysiol. 2010; 3:105–114. doi: 10.1161/CIRCEP.110.853804.LinkGoogle Scholar
    • 5. Bray MA, Wikswo JP. Considerations in phase plane analysis for nonstationary reentrant cardiac behavior.Phys Rev E Stat Nonlin Soft Matter Phys. 2002; 65(5 pt 1):051902. doi: 10.1103/PhysRevE.65.051902.CrossrefMedlineGoogle Scholar
    • 6. Rodrigo M, Climent AM, Liberos A, Fernández-Avilés F, Berenfeld O, Atienza F, Guillem MS. Technical considerations on phase mapping for identification of atrial reentrant activity in direct- and inverse-computed electrograms.Circ Arrhythm Electrophysiol. 2017; 10:e005008. doi: 10.1161/CIRCEP.117.005008.LinkGoogle Scholar
    • 7. Kuramoto Y, Shima S-I. Rotating spirals without phase singularity in reaction-diffusion systems.Progr Theor Phys Supp. 2003; 150:115–125.CrossrefGoogle Scholar
    • 8. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart.Circulation. 2000; 101:194–199.LinkGoogle Scholar
    • 9. Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.J Am Coll Cardiol. 2012; 60:628–636. doi: 10.1016/j.jacc.2012.05.022.CrossrefMedlineGoogle Scholar
    • 10. Alhusseini M, Vidmar D, Meckler GL, Kowalewski CA, Shenasa F, Wang PJ, Narayan SM, Rappel WJ. Two independent mapping techniques identify rotational activity patterns at sites of local termination during persistent atrial fibrillation.J Cardiovasc Electrophysiol. 2017; 28:615–622. doi: 10.1111/jce.13177.CrossrefMedlineGoogle Scholar
    • 11. Halbfass P, Müller P, Nentwich K, Sonne K, Hamm K, Barth S, Fochler F, Mügge A, Deneke T. Repetitive atrial activation during ongoing atrial fibrillation-comparison using different mapping algorithms: preliminary findings.J Interv Card Electrophysiol. 2017; 49:67–74. doi: 10.1007/s10840-017-0244-8.CrossrefMedlineGoogle Scholar
    • 12. Rodrigo M, Climent AM, Liberos A, Fernández-Avilés F, Berenfeld O, Atienza F, Guillem MS. Highest dominant frequency and rotor positions are robust markers of driver location during noninvasive mapping of atrial fibrillation: a computational study.Heart Rhythm. 2017; 14:1224–1233. doi: 10.1016/j.hrthm.2017.04.017.CrossrefMedlineGoogle Scholar
    • 13. Miller JM, Kowal RC, Swarup V, Daubert JP, Daoud EG, Day JD, Ellenbogen KA, Hummel JD, Baykaner T, Krummen DE, Narayan SM, Reddy VY, Shivkumar K, Steinberg JS, Wheelan KR. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.J Cardiovasc Electrophysiol. 2014; 25:921–929. doi: 10.1111/jce.12474.CrossrefMedlineGoogle Scholar
    • 14. Narayan SM, Baykaner T, Clopton P, Schricker A, Lalani GG, Krummen DE, Shivkumar K, Miller JM. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation).J Am Coll Cardiol. 2014; 63:1761–1768. doi: 10.1016/j.jacc.2014.02.543.MedlineGoogle Scholar
    • 15. Haissaguerre M, Hocini M, Denis A, Shah AJ, Komatsu Y, Yamashita S, Daly M, Amraoui S, Zellerhoff S, Picat MQ, Quotb A, Jesel L, Lim H, Ploux S, Bordachar P, Attuel G, Meillet V, Ritter P, Derval N, Sacher F, Bernus O, Cochet H, Jais P, Dubois R. Driver domains in persistent atrial fibrillation.Circulation. 2014; 130:530–538. doi: 10.1161/CIRCULATIONAHA.113.005421.LinkGoogle Scholar
    • 16. Cuculich PS, Wang Y, Lindsay BD, Faddis MN, Schuessler RB, Damiano RJ, Li L, Rudy Y. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns.Circulation. 2010; 122:1364–1372. doi: 10.1161/CIRCULATIONAHA.110.945709.LinkGoogle Scholar
    • 17. Buch E, Mandapati R. The continuing search for patient-specific atrial fibrillation ablation targets: need for rigorously verified and independently replicated data.Heart Rhythm. 2016; 13:2331–2332. doi: 10.1016/j.hrthm.2016.08.033.CrossrefMedlineGoogle Scholar
    • 18. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, Crijns HJ. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation.Circ Arrhythm Electrophysiol. 2010; 3:606–615. doi: 10.1161/CIRCEP.109.910125.LinkGoogle Scholar
    • 19. de Groot N, van der Does L, Yaksh A, Lanters E, Teuwen C, Knops P, van de Woestijne P, Bekkers J, Kik C, Bogers A, Allessie M. Direct proof of endo-epicardial asynchrony of the atrial wall during atrial fibrillation in humans.Circ Arrhythm Electrophysiol. 2016; 9:e003648.LinkGoogle Scholar
    • 20. Lee S, Sahadevan J, Khrestian CM, Markowitz A, Waldo AL. Characterization of foci and breakthrough sites during persistent and long-standing persistent atrial fibrillation in patients: studies using high-density (510–512 electrodes) biatrial epicardial mapping.J Am Heart Assoc. 2017; 6:e005274.LinkGoogle Scholar
    • 21. Roney CH, Cantwell CD, Bayer JD, Qureshi NA, Lim PB, Tweedy JH, Kanagaratnam P, Peters NS, Vigmond EJ, Ng FS. Spatial resolution requirements for accurate identification of drivers of atrial fibrillation.Circ Arrhythm Electrophysiol. 2017; 10:e004899. doi: 10.1161/CIRCEP.116.004899.LinkGoogle Scholar
    • 22. King B, Porta-Sánchez A, Massé S, Zamiri N, Balasundaram K, Kusha M, Jackson N, Haldar S, Umapathy K, Nanthakumar K. Effect of spatial resolution and filtering on mapping cardiac fibrillation.Heart Rhythm. 2017; 14:608–615. doi: 10.1016/j.hrthm.2017.01.023.CrossrefMedlineGoogle Scholar
    • 23. Kuklik P, Zeemering S, van Hunnik A, Maesen B, Pison L, Lau D, Maessen J, Podziemski P, Meyer C, Schaffer B, Crijns H, Willems S, Schotten U. Identification of rotors during human atrial fibrillation using contact mapping and phase singularity detection: technical considerations.IEEE Trans Biomed Eng. 2017; 64:310–318.CrossrefMedlineGoogle Scholar